Log in Book a Demo

US Pharma & Biotech Pharmacology - PPC Market Share Analysis May 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Pharmacology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Pharmacology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
ro.co 14.21
goodlifemeds.com 9.63
maximustribe.com 5.93
ivyrx.com 4.52
lilly.com 4.1
boironusa.com 3.18
citizenmeds.com 3.13
wegovy.com 2.92
novomedlink.com 2.53
biktarvy.com 2.39
others 47.46

Copyright © Adthena. All rights reserved.

In the competitive landscape of Google PPC, ‘ro.co’ leads with a 14.21% click share, followed by ‘goodlifemeds.com’ at 9.63%. ‘Others’ dominate with 47.46%, highlighting diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Pharmacology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date ro.co goodlifemeds.com citizenmeds.com ivyrx.com biktarvy.com novomedlink.com wegovy.com lilly.com maximustribe.com forbes.com
2025/05/01 19.37% 16.88% 4.42% 3.8% 5.06% 0.51% 1.06% 1.85% 6.28% 4.15%
2025/05/02 15.28% 11.11% 3.77% 4.95% 2.99% 2.04% 5.71% 0.56% 8.8% 0.63%
2025/05/03 14.13% 18.81% 3.82% 5.24% 3.61% 2.78% 2.33% 1.63% 8.95% 0.72%
2025/05/04 15.96% 12.18% 5.38% 8.87% 3.51% 5.44% 5.34% 3.86% 9.25% 0.11%
2025/05/05 19.4% 14.98% 11.2% 4.68% 3.97% 2.93% 1.99% 0.87% 3.55% 1.49%
2025/05/06 21.18% 11.24% 7.15% 4.08% 2.54% 3.02% 2.84% 11.66% 1.79% 5.1%
2025/05/07 15.61% 15.23% 6.86% 6.32% 3.05% 5.24% 2.04% 8.68% 2.15% 0.18%
2025/05/08 16.24% 12.28% 3.98% 4.68% 4.29% 9.01% 4.6% 3.3% 2.95% 1.47%
2025/05/09 22.45% 12.05% 6.45% 3.4% 2.13% 3.82% 1.74% 7.11% 3.18% 5.2%
2025/05/10 18.47% 13.23% 5.18% 6.01% 4.01% 4.31% 4% 1.01% 5.35% 0.53%
2025/05/11 19.74% 12.15% 2.52% 2.75% 1.78% 3.18% 1.54% 15.11% 3.92% 8.82%
2025/05/12 21.05% 13.17% 2.48% 4.24% 2.38% 2.37% 3.37% 6.85% 3.79% 1.02%
2025/05/13 18.66% 14.54% 6.77% 7.49% 3.9% 3.16% 1.7% 1.43% 4.82% 0.95%
2025/05/14 14.19% 16.57% 5.35% 5.32% 2.6% 4.49% 5.96% 1.49% 5.33% 1.18%
2025/05/15 17.6% 16.31% 1.49% 3.44% 2.1% 7.07% 4.92% 2.95% 2.3% 1.15%
2025/05/16 23.59% 11.81% 4.57% 1.93% 2.56% 5.54% 2.86% 1.9% 2.09% 9.02%
2025/05/17 16.67% 7.04% 3.68% 7.26% 4.02% 5.06% 2.36% 2.43% 3.69% 1.15%
2025/05/18 14.14% 13.42% 6.21% 5.28% 2.25% 5.12% 1.29% 5.76% 2.69% 11.91%
2025/05/19 16.82% 13.49% 3.96% 5.85% 3.41% 5.33% 3.28% 0.78% 4.36% 0.22%
2025/05/20 26.61% 8.3% 4.06% 7.36% 3.43% 3.7% 3.05% 0.66% 3.42% 0.12%
2025/05/21 16.64% 10.51% 0.99% 7.86% 2.45% 4.11% 5.48% 3.35% 2.24% 1.49%
2025/05/22 18.59% 9.94% 1.73% 8.63% 3.1% 4.88% 3.78% 1.62% 6.85% 0.57%
2025/05/23 18% 6.87% 1.05% 7% 3.3% 10.83% 5.11% 3.19% 7.02% 1.67%
2025/05/24 22.18% 18.88% 3.28% 4.05% 2.88% 6.88% 3.3% 1.68% 3.08% 0.95%
2025/05/25 16.8% 10.72% 0.08% 7.52% 3.31% 2.76% 6.4% 2.39% 6.44% 1.64%
2025/05/26 21.7% 10.12% 0.74% 2.92% 3.06% 6.72% 0.68% 2.05% 4.01% 4.41%
2025/05/27 16.19% 11.56% 1.6% 6.99% 3.28% 4.39% 2.68% 3.67% 4.27% 1.76%
2025/05/28 23.61% 10.24% 0.02% 5.28% 3.95% 5.53% 2.3% 9.19% 3.44% 1.64%
2025/05/29 20.21% 15.57% 1.9% 5.09% 3.14% 7.16% 2.49% 3.63% 1.76% 1.74%
2025/05/30 20.63% 8.5% 0.68% 6.85% 2.85% 7.52% 5.32% 2.43% 3.47% 0.43%
2025/05/31 23.48% 8.37% 6.34% 5.08% 3.83% 3.75% 3.42% 2.32% 2.16% 0.13%

Copyright © Adthena. All rights reserved.

In May 2025, ro.co led PPC spend, peaking at 26.61% on May 20. Goodlifemeds.com fluctuated, ending at 8.37%. Citizenmeds.com saw a low of 0.02% on May 28. Ivyrx.com maintained steady growth, closing at 5.08%. Biktarvy.com remained stable, finishing at 3.83%. Novomedlink.com peaked at 10.83% on May 23. Wegovy.com showed variability, ending at 3.42%. Lilly.com had a notable spike on May 11 at 15.11%. Maximustribe.com started strong, then declined, ending at 2.16%. Forbes.com had sporadic activity, closing at 0.13%.

Market Exposure

Competitor Count for US Pharma & Biotech Pharmacology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/05/01 312
2025/05/02 312
2025/05/03 309
2025/05/04 329
2025/05/05 318
2025/05/06 348
2025/05/07 318
2025/05/08 311
2025/05/09 312
2025/05/10 302
2025/05/11 326
2025/05/12 324
2025/05/13 344
2025/05/14 324
2025/05/15 315
2025/05/16 322
2025/05/17 343
2025/05/18 337
2025/05/19 333
2025/05/20 340
2025/05/21 340
2025/05/22 316
2025/05/23 318
2025/05/24 300
2025/05/25 311
2025/05/26 331
2025/05/27 315
2025/05/28 317
2025/05/29 311
2025/05/30 321
2025/05/31 322

Copyright © Adthena. All rights reserved.

In May 2025, distinct advertisers fluctuated, peaking at 348 on May 6. The month concluded with 322 advertisers, reflecting a dynamic advertising landscape.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Pharmacology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
joinamble.com 2.02%
joinmochi.com 1.17%
ivyrx.com 0.87%
boironusa.com 0.7%
tryeden.com 0.7%
agelessrx.com -1.32%
nurx.com -1.32%
goodlifemeds.com -1.48%
citizenmeds.com -2.47%
lilly.com -2.61%

Copyright © Adthena. All rights reserved.

Joinamble.com surged with a 2.02% click share increase, while lilly.com faced a 2.61% decline.

Campaign Efficiency

US Pharma & Biotech Pharmacology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date ro.co goodlifemeds.com citizenmeds.com maximustribe.com ivyrx.com joinamble.com lilly.com novomedlink.com agelessrx.com forbes.com
2025/05/01 17.94% 14.16% 4.26% 11.15% 4.37% 0% 1.41% 0.37% 3.76% 3.9%
2025/05/02 15.36% 9.6% 4.19% 15.87% 4.34% 0% 0.58% 1.28% 5.41% 0.52%
2025/05/03 11.27% 14.21% 3.42% 14.19% 5.46% 0% 1.74% 1.55% 4.56% 0.68%
2025/05/04 12.25% 10.19% 5.24% 16.05% 8.19% 0% 3.59% 2.89% 1.28% 0.13%
2025/05/05 17.38% 12.65% 11.34% 5.31% 5.46% 0% 1.06% 1.72% 2% 1.46%
2025/05/06 19.97% 10.22% 7.1% 3.57% 4.24% 0% 8.3% 1.78% 1.52% 4.94%
2025/05/07 12.57% 14.35% 6.64% 4.94% 6.47% 0% 5.53% 2.8% 2.89% 0.2%
2025/05/08 13.16% 10.33% 4.06% 6.24% 5.27% 0.32% 3.65% 5.38% 2.67% 1.64%
2025/05/09 19.26% 9.44% 6.13% 4.66% 3.94% 1.33% 4.61% 2.2% 1.75% 4.38%
2025/05/10 14.33% 10.44% 4.95% 10.7% 5.55% 3.44% 1.01% 2.38% 1.96% 0.48%
2025/05/11 19% 9.67% 2.25% 7.85% 2.68% 1.47% 10.81% 1.96% 2.37% 10.32%
2025/05/12 21.06% 11.45% 2.64% 7.34% 3.59% 1.38% 4.66% 1.45% 3.94% 1.1%
2025/05/13 19.04% 11.69% 7.57% 7.18% 6.67% 1.86% 1.41% 1.57% 2.82% 0.9%
2025/05/14 13.56% 13.28% 4.71% 9.66% 3.93% 2.22% 1.3% 2.35% 3.23% 1.48%
2025/05/15 16.54% 14.52% 1.21% 4.48% 2.76% 2.29% 3.49% 3.9% 3.48% 1.39%
2025/05/16 24.74% 11% 5.29% 4.3% 1.84% 1.56% 1.63% 3.09% 2.92% 9.75%
2025/05/17 14.83% 5.29% 2.97% 7.61% 7.38% 3.09% 1.89% 2.77% 3.47% 1.22%
2025/05/18 13.14% 11.12% 5.79% 5.24% 4.99% 3.2% 4.02% 2.96% 2.98% 10.3%
2025/05/19 13.67% 10.75% 3.36% 9.34% 5.79% 4.98% 0.43% 2.72% 2.97% 0.3%
2025/05/20 22.3% 6.88% 3.74% 6.74% 6.41% 3.05% 0.75% 2.22% 2.88% 0.14%
2025/05/21 15.07% 9.29% 0.71% 5.84% 6.9% 2.44% 2.92% 2.05% 1.93% 1.6%
2025/05/22 14.26% 8.89% 1.19% 11.02% 9.61% 6.21% 1.74% 2.58% 0.18% 0.51%
2025/05/23 16.38% 5.88% 0.77% 11.67% 6.03% 2.6% 2.87% 5.85% 2.03% 1.52%
2025/05/24 22.63% 18.09% 4.58% 6.78% 3.55% 4.57% 1.8% 3.67% 0.03% 0.84%
2025/05/25 13.3% 7.84% 0.04% 11.79% 5.69% 9.61% 2.23% 1.47% 1.1% 1.63%
2025/05/26 20.76% 7.1% 0.53% 5.78% 2.61% 5.32% 1.92% 3.42% 0.02% 5.36%
2025/05/27 13.65% 8.6% 1.15% 7.69% 5.26% 4.73% 3.17% 2.28% 0.04% 1.86%
2025/05/28 23.05% 7.85% 0.01% 7.89% 3.83% 3.24% 8.21% 3.2% 0.03% 1.83%
2025/05/29 18.45% 12.16% 1.34% 4.03% 4.37% 2.88% 3.71% 4.67% 0.03% 1.64%
2025/05/30 18.53% 6.18% 0.51% 7.78% 5.69% 4.85% 2.44% 4.38% 0.16% 0.47%
2025/05/31 18.89% 6.81% 6% 5.69% 3.86% 2.84% 2.63% 2.51% 1.61% 0.16%

Copyright © Adthena. All rights reserved.

In May 2025, ro.co led with fluctuating impressions, peaking at 24.74% on the 16th. Goodlifemeds.com saw a notable dip mid-month, while maximustribe.com maintained a steady presence. By month’s end, ro.co remained dominant.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Pharmacology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    Semaglutide Shipped Overnight - Semaglutide Injections $135 https://www.citizenmeds.com/

    Fastest and Most affordable Semaglutide Shipped Overnight - $135. Our Semaglutide Injections are In-Stock, See a Doctor Today.

  2. 2
    Best Sites to Get Tirzepatide - There's One Clear Winner 2025 https://www.forbes.com/tirzepatide/weight-loss

    Mark May 2025 As The Month You Begin Your Transformation—Lose Weight With Ease!

  3. 3
    Tirzepatide - Lilly Medicines - View Product Information http://tirzepatide.lilly.com/

    Indications & Safety Summary With Warnings. Learn About Our Prescription-Only, FDA-Approved Medicines Containing Tirzepatide.

  4. 4
    Semaglutide Product Options - FDA-Approved Medicines https://www.novomedlink.com/

    Novo Nordisk®, The Only Manufacturer Of FDA-Approved Semaglutide Medicines. Learn More. Discover Semaglutide Products.

  5. 5
    Start Tirzepatide For Just $45 - No Insurance Required https://www.ro.co/glp-1/zepbound

    See safety info & box warning. Rx only, if appropriate. $45 1st, then $145/mo. Meds excl

Copyright © Adthena. All rights reserved.

In the competitive landscape of pharmaceuticals, Citizen Meds stands out with its promise of overnight delivery for Semaglutide at $135, emphasizing speed and affordability. Forbes highlights Tirzepatide as a transformative weight-loss solution, marking May 2025 as pivotal. Lilly and Novo Nordisk focus on FDA-approved medicines, underscoring safety and credibility. Meanwhile, Ro.co offers Tirzepatide at an accessible price, appealing to cost-conscious consumers.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

Related reports

US
Pharma & Biotech

US Research and Development

US
Pharma & Biotech

US Pulmonology

UK
Pharma & Biotech

UK Pharmacology

UK
Pharma & Biotech

UK Research and Development